Brief: RaQualia Pharma receives patent recognition for sodium channel blocker from EU

RaQualia Pharma

07/07/2016 07:17

July 7 (Reuters) - RaQualia Pharma Inc  4579.T :  
     
    * Says it received patent recognition for its sodium channel 
blocker from Europe 
    * Says sodium channel blocker is a medicine used to relieve 
the pain 
     
     
    Source text in Japanese:https://goo.gl/nudSfa 
    Further company coverage: 4579.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724; 
Reuters Messaging: jun.cao.reuters.com@reuters.net))